Literature DB >> 20461560

Patent foramen ovale and stroke: Should PFOs be closed in otherwise cryptogenic stroke?

David A Carpenter1, Andria L Ford, Jin-Moo Lee.   

Abstract

Since initial reports of its association with ischemic stroke appeared in 1988, there has been continued controversy regarding the existence and strength of the association between patent foramen ovale (PFO) and ischemic stroke. Many case-control studies have reported an association between incident cryptogenic ischemic stroke and PFO, yet population-based studies have failed to confirm this association. Studies of the risk of recurrent stroke in patients with cryptogenic stroke with or without PFO have not shown an increased risk of recurrent stroke in patients with PFO. Meanwhile, use of devices to close PFOs and atrial septal defects percutaneously has increased dramatically since their introduction. Completion of the randomized clinical trials of PFO closure currently in progress is vital to determine if the benefits of PFO closure in cryptogenic stroke outweigh its risks.

Entities:  

Mesh:

Year:  2010        PMID: 20461560     DOI: 10.1007/s11883-010-0114-7

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  40 in total

1.  Migrating thrombus trapped in a patent foramen ovale.

Authors:  A Kessel-Schaefer; M Lefkovits; M J Zellweger; W Brett; F Rüter; M E Pfisterer; P Buser
Journal:  Circulation       Date:  2001-04-10       Impact factor: 29.690

Review 2.  Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis.

Authors:  Alessandro Pezzini; Mario Grassi; Elisabetta Del Zotto; Alessia Giossi; Irene Volonghi; Paolo Costa; Armin Grau; Mauro Magoni; Alessandro Padovani; Christoph Lichy
Journal:  Thromb Haemost       Date:  2009-05       Impact factor: 5.249

3.  Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study.

Authors:  Irene Meissner; Bijoy K Khandheria; John A Heit; George W Petty; Sheldon G Sheps; Gary L Schwartz; Jack P Whisnant; David O Wiebers; Jody L Covalt; Tanya M Petterson; Teresa J H Christianson; Yoram Agmon
Journal:  J Am Coll Cardiol       Date:  2005-12-06       Impact factor: 24.094

4.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors:  J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

5.  Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study.

Authors:  P L Kolominsky-Rabas; M Weber; O Gefeller; B Neundoerfer; P U Heuschmann
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

6.  Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study.

Authors:  Joaquín Serena; Joan Marti-Fàbregas; Estevo Santamarina; Juan Jesús Rodríguez; María Jesús Perez-Ayuso; Jaime Masjuan; Tomás Segura; Jaime Gállego; Antonio Dávalos
Journal:  Stroke       Date:  2008-09-25       Impact factor: 7.914

7.  Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study.

Authors:  Steven C Cramer; Guy Rordorf; Jeffrey H Maki; Larry A Kramer; James C Grotta; W Scott Burgin; Judith A Hinchey; Curtis Benesch; Karen L Furie; Helmi L Lutsep; Ellen Kelly; W T Longstreth
Journal:  Stroke       Date:  2003-12-04       Impact factor: 7.914

8.  Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.

Authors:  Stephan Windecker; Andreas Wahl; Krassen Nedeltchev; Marcel Arnold; Markus Schwerzmann; Christian Seiler; Heinrich P Mattle; Bernhard Meier
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

9.  Patent foramen ovale: is stroke due to paradoxical embolism?

Authors:  D Ranoux; A Cohen; L Cabanes; P Amarenco; M G Bousser; J L Mas
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.

Authors:  Patrick T O'Gara; Steven R Messe; E Murat Tuzcu; Gloria Catha; John C Ring
Journal:  Circulation       Date:  2009-05-11       Impact factor: 29.690

View more
  2 in total

1.  Cardiovascular diseases in patients 65 years and younger with non-cardiogenic stroke.

Authors:  Anetta Lasek-Bal; Zbigniew Gąsior
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

Review 2.  Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.

Authors:  Jie Li; Junfeng Liu; Ming Liu; Shihong Zhang; Zilong Hao; Jing Zhang; Canfei Zhang
Journal:  Cochrane Database Syst Rev       Date:  2015-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.